ArticleFrontiers in neurology2024

Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients.

Pan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.